ik-930
ikena oncology
['ik-930', 'ikena ']
ikena oncology shares differentiation profile of ik-930, a novel hippo-pathway inhibitor, including projected therapeutic index advantages and breadth of patient populations at aacr 2023 annual meeting - is a potent hippo pathway inhibitor that selectiv... 
CEO Of Digital Media Online